Reliably Assessing Duration of Protection for COVID-19 Vaccines
Dan-Yu Lin, Donglin Zeng, Yu Gu, Thomas R Fleming, Philip R Krause
doi: https://doi.org/10.1101/2021.12.22.21268201
Dan-Yu Lin
1University of North Carolina at Chapel Hill
Ph.DDonglin Zeng
1University of North Carolina at Chapel Hill
Ph.D.Yu Gu
1University of North Carolina at Chapel Hill
B.S.Thomas R Fleming
2University of Washington
Ph.D.Philip R Krause
3US Food and Drug Administration
M.D.Data Availability
There are no actual data in this manuscript
Posted December 27, 2021.
Reliably Assessing Duration of Protection for COVID-19 Vaccines
Dan-Yu Lin, Donglin Zeng, Yu Gu, Thomas R Fleming, Philip R Krause
medRxiv 2021.12.22.21268201; doi: https://doi.org/10.1101/2021.12.22.21268201
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2339)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11707)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3691)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2371)
- Health Policy (927)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3456)
- Nursing (195)
- Nutrition (520)
- Oncology (1804)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6093)
- Radiology and Imaging (1260)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)